Charles Hurty - IShares Healthcare Independent Trustee
| IYH Etf | USD 61.30 0.56 0.92% |
Mr. Charles A. Hurty serves as Independent Trustee of Ishares Trust Dow Jones United States. He was a Trustee of the Trust since 2005 and Chairman of the Audit Committee of the Trust since 2006. Mr. Hurty has served as a Director of iShares, Inc. since 2005, Chairman of the Audit Committee of iShares, Inc. since 2006, a Director of iShares MSCI Russia Capped Index Fund, Inc. since 2010 and Chairman of the Audit Committee of iShares MSCI Russia Capped Index Fund, Inc. since 2010. In addition, Mr. Hurty serves as Director of the GMAM Absolute Return Strategy Fund since 2002, Director of the SkyBridge MultiAdviser Hedge Fund Portfolios LLC since 2002 and was a Director of the CSFB Alternative Investment Funds from 2005 to December 2009, when the funds were liquidated. Mr. Hurty was formerly a Partner at KPMG, LLP from 1968 to 2001
| Age | 72 |
| Tenure | 19 years |
| Issuer | iShares |
| Inception Date | 2000-06-12 |
| Benchmark | Russell 1000 Health Care RIC 22.5/45 Capped Index |
| Entity Type | Regulated Investment Company |
| Asset Under Management | 3.22 Billion |
| Average Trading Valume | 276,851.2 |
| Asset Type | Equity |
| Category | Sector |
| Focus | Health Care |
| Market Concentration | Developed Markets |
iShares Healthcare ETF Money Managers
| Geoffrey Flynn, Chief Operating Officer, Executive Vice President | ||
| Robert Silver, Independent Trustee | ||
| John Kerrigan, Independent Trustee | ||
| Madhav Rajan, Independent Trustee | ||
| Matt Tucker, Vice President | ||
| Cecilia Herbert, Independent Trustee | ||
| Michael Latham, President Trustee | ||
| Jack Gee, Chief Financial Officer, Treasurer | ||
| Charles Hurty, Independent Trustee | ||
| Eilleen Clavere, Secretary | ||
| George Parker, Independent Chairman of the Board of Trustees | ||
| John Martinez, Independent Trustee | ||
| Amy Schioldager, Executive Vice President | ||
| Robert Kapito, Trustee | ||
| Ira Shapiro, Vice President Chief Legal Officer |
IShares Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is IShares Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Price To Earning | 5.09 X | |||
| Price To Book | 2.95 X | |||
| Price To Sales | 2.10 X | |||
| Gross Profit | 37.51 M | |||
| Earnings Per Share | (7.39) X | |||
| Number Of Employees | 15 | |||
| Beta | 0.69 | |||
| Market Capitalization | 3.19 B | |||
| Total Asset | 2.92 B | |||
| One Year Return | 12.60 % |
Currently Active Assets on Macroaxis
When determining whether iShares Healthcare ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IShares Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ishares Healthcare Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Ishares Healthcare Etf:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iShares Healthcare ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
The market value of iShares Healthcare ETF is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Healthcare's value that differs from its market value or its book value, called intrinsic value, which is IShares Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Healthcare's market value can be influenced by many factors that don't directly affect IShares Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.